CollPlant Biotechnologies CLGN
NASDAQ CLGN
$3.42 -0.15 (-4.20%)
At close: Oct 2, 2026 · 4:00 PM EDT

CollPlant Biotechnologies (CLGN) Revenue (2017 - 2026)

Updated

CollPlant Biotechnologies' Revenue came in at $108,000 for the quarter ended Jun 30, 2026, down 39.7% from $179,000 a year earlier but up 47.9% from the prior quarter.

Analysis

CollPlant Biotechnologies (CLGN) Revenue (2017 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, CollPlant Biotechnologies reported Revenue of $318,000, down 86.8% year-over-year; for the year ended Dec 31, 2025, it came in at $2.37 million, up 360.4% from the prior year.

  • Revenue carries a five-year compound annual growth rate of -17.3% (years ended Dec 2020 to Dec 2025).
  • Going back by year, Revenue was $515,000 in the year ended Dec 31, 2024 (-95.3%), $10.96 million in the year ended Dec 31, 2023, $299,000 in the year ended Dec 31, 2022 (-98.1%) and $15.64 million in the year ended Dec 31, 2021 (+154.9%).
  • The five-year range for quarterly Revenue is $4,000 (the quarter ended Sep 30, 2024) to $10.18 million (the quarter ended Jun 30, 2023).
  • Year-over-year, Revenue has declined for three consecutive quarters, with an average decline of 60.6% over the last six quarters.
  • The fastest year-over-year change in Revenue over five years came in the quarter ended Dec 31, 2023 (growth of 415.5%), and the weakest in the quarter ended Jun 30, 2024 (a decline of 97.6%).
  • Business Quant data shows CLGN's Revenue at $73,000 (quarter ended Mar 30, 2026), $60,000 (quarter ended Dec 31, 2025) and $77,000 (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 25.31 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 16.99 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 15.38 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 7.80 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 15.03 Bn
10 CollPlant Biotechnologies 4.57 Mn -24.87 Mn -456,000.00 108,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 108,000.00
Mar 30, 2026 73,000.00
Dec 31, 2025 60,000.00
Sep 30, 2025 77,000.00
Jun 30, 2025 179,000.00
Mar 30, 2025 2.06 Mn
Dec 31, 2024 164,000.00
Sep 30, 2024 4,000.00
Jun 30, 2024 249,000.00
Mar 31, 2024 98,000.00
Dec 31, 2023 299,000.00
Sep 30, 2023 43,000.00
Jun 30, 2023 10.18 Mn
Mar 31, 2023 433,000.00
Dec 31, 2022 58,000.00
Sep 30, 2022 109,000.00
Jun 30, 2022 66,000.00
Dec 31, 2021 310,000.00
Sep 30, 2021 140,000.00
Jun 30, 2021 691,000.00
API Access

CollPlant Biotechnologies Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=CLGN&period=max&api_key=YOUR_API_KEY